On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B

BACKGROUND & AIMS: The vast majority of studies evaluating differences in on-treatment risks of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) have been conducted in Asia. Data on the course of CHB on antiviral therapy among predominantly non-Asian populations is less...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zeyuan, Cheung, Ramsey C., Chitnis, Amit S., Zhang, Wei, Gish, Robert G., Wong, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494462/
https://www.ncbi.nlm.nih.gov/pubmed/37701335
http://dx.doi.org/10.1016/j.jhepr.2023.100852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494462/
https://www.ncbi.nlm.nih.gov/pubmed/37701335
http://dx.doi.org/10.1016/j.jhepr.2023.100852

Ejemplares similares